NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 1.110
+0.028 (2.59%)
Feb 20, 2026, 5:23 PM CET
NFL Biosciences Revenue
NFL Biosciences had revenue of 79.00 EUR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 164.00. In the year 2024, NFL Biosciences had annual revenue of 46.00, down -99.98%.
Revenue (ttm)
164.00
Revenue Growth
-99.98%
P/S Ratio
85,769.45
Revenue / Employee
32.80
Employees
5
Market Cap
14.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.00 | -199.97K | -99.98% |
| Dec 31, 2023 | 200.01K | 199.99K | 909,040.91% |
| Dec 31, 2022 | 22.00 | -17.00 | -43.59% |
| Dec 31, 2021 | 39.00 | 36.00 | 1,200.00% |
| Dec 31, 2020 | 3.00 | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 27.16M |
| Poxel | 7.66M |
| Advicenne | 5.90M |
| Nicox | 3.32M |
| Aelis Farma | 2.33M |
| Plant Advanced Technologies | 2.22M |
| Oncodesign Precision Medicine Société anonyme | 1.74M |
| GenSight Biologics | 945.00K |